{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:16:38Z","timestamp":1790712998944,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03459-7","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:47:16Z","timestamp":1779914836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the Impact of Particle Size and Crystal Habit of Mesalamine Drug Substances on Their Packing, Wetting, and Dissolution Behaviour: A Science-based Approach for Selection of API Vendor"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4148-171X","authenticated-orcid":false,"given":"Prakash Kumar","family":"Sirvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9362-8365","authenticated-orcid":false,"given":"Ayush","family":"Rohila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1062-5860","authenticated-orcid":false,"given":"Sakshi","family":"Kunjir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-7750","authenticated-orcid":false,"given":"Sadhana","family":"Dhyagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0603-1492","authenticated-orcid":false,"given":"Ankit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-6115","authenticated-orcid":false,"given":"Rajkumar","family":"Malayandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"3459_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.oprd.6b00434","volume":"21","author":"N Pudasaini","year":"2017","unstructured":"Pudasaini N, Upadhyay PP, Parker CR, Hagen SU, Bond AD, Rantanen J. Downstream processability of crystal habit-modified active pharmaceutical ingredient. Org Process Res Dev. 2017;21:571\u20137. https:\/\/doi.org\/10.1021\/acs.oprd.6b00434.","journal-title":"Org Process Res Dev"},{"key":"3459_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s42452-025-07712-9","volume":"7","author":"AA Alemie","year":"2025","unstructured":"Alemie AA, Siraj EA, Yayehrad AT, Tafere C, Tessema TA, Belete A. Continuous pharmaceutical manufacturing and its contemporary regulatory insights. Discov Appl Sci. 2025;7:1057. https:\/\/doi.org\/10.1007\/s42452-025-07712-9.","journal-title":"Discov Appl Sci"},{"key":"3459_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/929248","author":"E Bojnanska","year":"2014","unstructured":"Bojnanska E, Kalina M, Parizek L, Bartonickova E, Opravil T, Vesely M, et al. Determination of critical parameters of drug substance influencing dissolution: a case study. BioMed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/929248.","journal-title":"BioMed Res Int"},{"issue":"6","key":"3459_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12247-025-10134-0","volume":"20","author":"A Rohila","year":"2025","unstructured":"Rohila A, Kumar A, Sirvi PK, Dhyagala S, Kunjir S, Malayandi R. Patent landscaping of time-dependent mesalamine prolonged-release granules: a case study for generic formulation development. J Pharm Innov. 2025;20(6):218. https:\/\/doi.org\/10.1007\/s12247-025-10134-0.","journal-title":"J Pharm Innov"},{"key":"3459_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jconrel.2022.04.024","volume":"346","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wo SK, Leng W, Gao F, Yan X, Zuo Z. Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets. J Control Release. 2022;346:275\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.024.","journal-title":"J Control Release"},{"key":"3459_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/ibd.21193","volume":"16","author":"H Ito","year":"2010","unstructured":"Ito H, Iida M, Matsumoto T, Suzuki Y, Sasaki H, Yoshida T, et al. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study. Inflamm Bowel Dis. 2010;16:1567\u201374. https:\/\/doi.org\/10.1002\/ibd.21193.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"3459_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13346-013-0185-4","volume":"4","author":"R Malayandi","year":"2014","unstructured":"Malayandi R, Kondamudi PK, Ruby PK, Aggarwal D. Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease. Drug Deliv Transl Res. 2014;4(2):187\u2013202. https:\/\/doi.org\/10.1007\/s13346-013-0185-4.","journal-title":"Drug Deliv Transl Res"},{"key":"3459_CR8","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1021\/cg501084a","volume":"14","author":"SR Modi","year":"2014","unstructured":"Modi SR, Dantuluri AKR, Perumalla SR, Sun CC, Bansal AK. Effect of crystal habit on intrinsic dissolution behavior of celecoxib due to differential wettability. Cryst Growth Des. 2014;14:5283\u201392. https:\/\/doi.org\/10.1021\/cg501084a.","journal-title":"Cryst Growth Des"},{"key":"3459_CR9","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1021\/cg400140a","volume":"13","author":"SR Modi","year":"2013","unstructured":"Modi SR, Dantuluri AKR, Puri V, Pawar YB, Nandekar P, Sangamwar AT, et al. Impact of crystal habit on biopharmaceutical performance of celecoxib. Cryst Growth Des. 2013;13:2824\u201332. https:\/\/doi.org\/10.1021\/cg400140a.","journal-title":"Cryst Growth Des"},{"key":"3459_CR10","doi-asserted-by":"publisher","unstructured":"Sun C, Grant DJW. Influence of crystal shape on the tableting performance of L\u2010lysine monohydrochloride dihydrate. J Pharm Sci. 2001;90:569\u201379.\u00a0https:\/\/doi.org\/10.1002\/1520-6017(200105)90:5<569::aid-jps1013>3.0.co;2-4.","DOI":"10.1002\/1520-6017(200105)90:5<569::aid-jps1013>3.0.co;2-4"},{"key":"3459_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.xphs.2017.12.005","volume":"107","author":"N Pudasaini","year":"2018","unstructured":"Pudasaini N, Parker CR, Hagen SU, Bond AD, Rantanen J. Role of solvent selection on crystal habit of 5-aminosalicylic acid\u2014combined experimental and computational approach. J Pharm Sci. 2018;107:1112\u201321. https:\/\/doi.org\/10.1016\/j.xphs.2017.12.005.","journal-title":"J Pharm Sci"},{"key":"3459_CR12","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.xphs.2024.02.001","volume":"113","author":"SM Shah","year":"2024","unstructured":"Shah SM, Chakraborty S, Dubey G, Yewale S, Sathe RY, Ramaswamy L, et al. Effect of differential surface anisotropy on dissolution behavior of Fenofibrate crystal habits: comparative study using USP Type 2 and Type 4 dissolution apparatuses. J Pharm Sci. 2024;113:1844\u201353. https:\/\/doi.org\/10.1016\/j.xphs.2024.02.001.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3459_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.powtec.2007.07.042","volume":"183","author":"A Hagsten","year":"2008","unstructured":"Hagsten A, Casper Larsen C, M\u00f8ller Sonnergaard J, Rantanen J, Hovgaard L. Identifying sources of batch to batch variation in processability. Powder Technol. 2008;183(2):213\u20139. https:\/\/doi.org\/10.1016\/j.powtec.2007.07.042.","journal-title":"Powder Technol"},{"key":"3459_CR14","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1039\/D4CE01170H","volume":"27","author":"NH Ram","year":"2025","unstructured":"Ram NH, Dhondale MR, Singh M, Mishra B, Agrawal AK, Healy AM, et al. The impact of crystal habit on the pharmaceutical properties of active pharmaceutical ingredients. CrystEngComm. 2025;27:4614\u201333. https:\/\/doi.org\/10.1039\/D4CE01170H.","journal-title":"CrystEngComm"},{"issue":"1","key":"3459_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12247-019-09424-1","volume":"16","author":"S D","year":"2021","unstructured":"D S, Muthudoss P, Khullar P, A RV. Micronization and agglomeration: understanding the impact of API particle properties on dissolution and permeability using solid state and biopharmaceutical \u201ctoolbox.\u201d J Pharm Innov. 2021;16(1):136\u201351. https:\/\/doi.org\/10.1007\/s12247-019-09424-1.","journal-title":"J Pharm Innov"},{"issue":"2","key":"3459_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","volume":"46","author":"E Baka","year":"2008","unstructured":"Baka E, Comer JEA, Tak\u00e1cs-Nov\u00e1k K. Study of equilibrium solubility measurement by saturation shake-flask method using Hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46(2):335\u201341. https:\/\/doi.org\/10.1016\/j.jpba.2007.10.030.","journal-title":"J Pharm Biomed Anal"},{"key":"3459_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11095-025-03891-7","volume":"42","author":"S Kunjir","year":"2025","unstructured":"Kunjir S, Pathare P, Sharma S, Deoriya J, Natesan S, Malayandi R. Influence of milling parameters on crystal morphology, thermal behavior, and dissolution of Mesalamine nanocrystals. Pharm Res. 2025;42:1409\u201327. https:\/\/doi.org\/10.1007\/s11095-025-03891-7.","journal-title":"Pharm Res"},{"key":"3459_CR18","doi-asserted-by":"publisher","unstructured":"Morris KR, Schlam RF, Cao W, Short MS. Determination of average crystallite shape by x\u2010ray diffraction and computational methods. J Pharm Sci. 2000;89:1432\u201342. https:\/\/doi.org\/10.1002\/1520-6017(200011)89:11<1432::aid-jps6>3.0.co;2-x","DOI":"10.1002\/1520-6017(200011)89:11<1432::aid-jps6>3.0.co;2-x"},{"key":"3459_CR19","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3390\/molecules26113469","volume":"26","author":"CU Phan","year":"2021","unstructured":"Phan CU, Shen J, Yu K, Mao J, Tang G. Impact of crystal habit on the dissolution rate and in vivo pharmacokinetics of Sorafenib Tosylate. Molecules. 2021;26:3469. https:\/\/doi.org\/10.3390\/molecules26113469.","journal-title":"Molecules"},{"key":"3459_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.cherd.2024.05.034","volume":"207","author":"M Singh","year":"2024","unstructured":"Singh M, Dhondale MR, Agrawal AK, Panda S, Kumar D. The potential of sonocrystallization in crystal habit modification for improving micromeritic and physicochemical properties of Dapagliflozin. Chem Eng Res Des. 2024;207:308\u201319. https:\/\/doi.org\/10.1016\/j.cherd.2024.05.034.","journal-title":"Chem Eng Res Des"},{"key":"3459_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejps.2004.02.011","volume":"22","author":"S Agrawal","year":"2004","unstructured":"Agrawal S, Ashokraj Y, Bharatam PV, Pillai O, Panchagnula R. Solid-state characterization of Rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci. 2004;22:127\u201344. https:\/\/doi.org\/10.1016\/j.ejps.2004.02.011.","journal-title":"Eur J Pharm Sci"},{"key":"3459_CR22","doi-asserted-by":"publisher","unstructured":"Sharma S, Kunjir SA, Pathare PR, Deoriya J, Sahoo A, Malayandi R. Effect of solid-state characteristics and buffers on the solubility and dissolution behaviors of mesalamine. J Therm Anal Calorim. 2025;150:9153\u201369. https:\/\/doi.org\/10.1007\/s10973-025-14231-7.","DOI":"10.1007\/s10973-025-14231-7"},{"key":"3459_CR23","doi-asserted-by":"publisher","unstructured":"Agimelen OS, Mulholland AJ, Sefcik J. Modelling of artefacts in estimations of particle size of needle-like particles from laser diffraction measurements. 2016;158:445-52. https:\/\/doi.org\/10.48550\/ARXIV.1603.03455.","DOI":"10.48550\/ARXIV.1603.03455"},{"key":"3459_CR24","doi-asserted-by":"publisher","unstructured":"Stauffer F, Vanhoorne V, Pilcer G, Chavez P-F, Vervaet C, De Beer T. Managing API raw material variability in a continuous manufacturing line \u2013 prediction of process robustness. Int J Pharm. 2019;569:118525. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118525.","DOI":"10.1016\/j.ijpharm.2019.118525"},{"key":"3459_CR25","doi-asserted-by":"publisher","unstructured":"Jikazana A, Garg K, Le Corre Pidou K, Campo P, McAdam EJ. The role of mixing on the kinetics of nucleation and crystal growth in membrane distillation crystallisation. Separation and Purification Technology. 2025;353:128533. https:\/\/doi.org\/10.1016\/j.seppur.2024.128533.","DOI":"10.1016\/j.seppur.2024.128533"},{"issue":"2","key":"3459_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/pharmaceutics14020291","volume":"14","author":"MA Garc\u00eda","year":"2022","unstructured":"Garc\u00eda MA, Varum F, Al-Gousous J, Hofmann M, Page S, Langguth P. In vitro methodologies for evaluating colon-targeted pharmaceutical products and industry perspectives for their applications. Pharmaceutics. 2022;14(2):291. https:\/\/doi.org\/10.3390\/pharmaceutics14020291.","journal-title":"Pharmaceutics"},{"key":"3459_CR27","doi-asserted-by":"publisher","unstructured":"Ren Y, Shen J, Yu K, Phan CU, Chen G, Liu J, et al. Impact of crystal habit on solubility of ticagrelor. Crystals. 2019;9:556. https:\/\/doi.org\/10.3390\/cryst9110556.","DOI":"10.3390\/cryst9110556"},{"issue":"16","key":"3459_CR28","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1039\/c2ce25336d","volume":"14","author":"R Montis","year":"2012","unstructured":"Montis R, Hursthouse MB. Surprisingly complex supramolecular behaviour in the crystal structures of a family of mono-substituted salicylic acids. CrystEngComm. 2012;14(16):5242. https:\/\/doi.org\/10.1039\/c2ce25336d.","journal-title":"CrystEngComm"},{"key":"3459_CR29","doi-asserted-by":"publisher","unstructured":"Holder CF, Schaak RE. Tutorial on powder x-ray diffraction for characterizing nanoscale materials. ACS Nano. 2019;13:7359\u201365. https:\/\/doi.org\/10.1021\/acsnano.9b05157.","DOI":"10.1021\/acsnano.9b05157"},{"issue":"4","key":"3459_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.xphs.2017.12.005","volume":"107","author":"N Pudasaini","year":"2018","unstructured":"Pudasaini N, Parker CR, Hagen SU, Bond AD, Rantanen J. Role of solvent selection on crystal habit of 5-Aminosalicylic Acid\u2014combined experimental and computational approach. J Pharm Sci. 2018;107(4):1112\u201321. https:\/\/doi.org\/10.1016\/j.xphs.2017.12.005.","journal-title":"J Pharm Sci"},{"key":"3459_CR31","doi-asserted-by":"publisher","unstructured":"Mirza S, Miroshnyk I, Hein\u00e4m\u00e4ki J, Antikainen O, Rantanen J, Vuorela P, et al. Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement. AAPS PharmSciTech. 2009;10:113\u20139. https:\/\/doi.org\/10.1208\/s12249-009-9187-4.","DOI":"10.1208\/s12249-009-9187-4"},{"key":"3459_CR32","doi-asserted-by":"publisher","first-page":"106135","DOI":"10.1016\/j.jddst.2024.106135","volume":"100","author":"S Zhou","year":"2024","unstructured":"Zhou S, Yang T, Qian C, Wu F, Hong Y, Lin X. An update on solid-state form, crystal modification and transition issues related to tablet manufacturing. J Drug Deliv Sci Technol. 2024;100:106135. https:\/\/doi.org\/10.1016\/j.jddst.2024.106135.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3459_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1208\/s12249-025-03320-3","volume":"27","author":"S Dhyagala","year":"2026","unstructured":"Dhyagala S, Kumar A, Sirvi PK, Kunjir S, Rohila A, Malayandi R. Reverse engineering of branded Mesalamine prolonged release granules for synthesis of QTPP and FMEA: A systematic approach for oral complex generic product development. AAPS PharmSciTech. 2026;27:108. https:\/\/doi.org\/10.1208\/s12249-025-03320-3.","journal-title":"AAPS PharmSciTech"},{"key":"3459_CR34","unstructured":"Patil PB. Development and Evaluation of Mesalamine Tablet Formulation for Colon Delivery. Res J Pharm Technol. 2011;1751\u20136."},{"issue":"1","key":"3459_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s43094-021-00299-z","volume":"7","author":"W Akram","year":"2021","unstructured":"Akram W, Garud N. Design expert as a statistical tool for optimization of 5-ASA-loaded biopolymer-based nanoparticles using Box Behnken factorial design. Futur J Pharm Sci. 2021;7(1):146. https:\/\/doi.org\/10.1186\/s43094-021-00299-z.","journal-title":"Futur J Pharm Sci"},{"issue":"2","key":"3459_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3329\/dujps.v18i2.44466","volume":"18","author":"MM Alam","year":"2019","unstructured":"Alam MM, Tasneem F, Kabir AL, Rouf ASS. Study of drug-drug and drug-food interactions of Mesalazine through FTIR and DSC. Dhaka Univ J Pharm Sci. 2019;18(2):257\u201369. https:\/\/doi.org\/10.3329\/dujps.v18i2.44466.","journal-title":"Dhaka Univ J Pharm Sci"},{"issue":"1","key":"3459_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.56808\/3027-7922.2070","volume":"37","author":"HH Gangurde","year":"2013","unstructured":"Gangurde HH, M A, Tamizharasi S, Sivakumar T. Statistical optimization of Mesalamine pulsatile release pH dependent coated pellets for possible ileo-cecal targeting. Thai J Pharm Sci. 2013;37(1):39\u201355. https:\/\/doi.org\/10.56808\/3027-7922.2070.","journal-title":"Thai J Pharm Sci"},{"key":"3459_CR38","doi-asserted-by":"publisher","first-page":"s554","DOI":"10.5530\/ijper.53.4s.150","volume":"53","author":"R Narayan Sahoo","year":"2019","unstructured":"Narayan Sahoo R, De A, Kataria V, Mallick S. Solvent-free hot melt extrusion technique in improving Mesalamine release for better management of Inflammatory Bowel Disease. Indian J Pharm Educ Res. 2019;53:s554\u201362. https:\/\/doi.org\/10.5530\/ijper.53.4s.150.","journal-title":"Indian J Pharm Educ Res"},{"issue":"1","key":"3459_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1872211308666140225143926","volume":"8","author":"AMJ Newton","year":"2014","unstructured":"Newton AMJ, Lakshmanan P. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of Chitosan\/ Pectin colon targeted Mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile. Drug Deliv Focus. 2014;8(1):46\u201362. https:\/\/doi.org\/10.2174\/1872211308666140225143926.","journal-title":"Drug Deliv Focus"},{"key":"3459_CR40","doi-asserted-by":"publisher","unstructured":"P. B. P. Development and Evaluation of Mesalamine Tablet Formulation for Colon Delivery. Research Journal of Pharmacy and Technology. 2011;1751\u20136. https:\/\/doi.org\/10.52711\/0974-360X.","DOI":"10.52711\/0974-360X"},{"key":"3459_CR41","unstructured":"Product monograph MEZERA\u00ae Mesalazine AVIR Pharma Inc. 2021. https:\/\/pdf.hres.ca\/dpd_pm\/00064140.PDF."},{"issue":"2","key":"3459_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.18231\/j.joapr.2024.12.2.93.108","volume":"12","author":"S Sahu","year":"2024","unstructured":"Sahu S, Choudhury PK, Pasa G, Murthy PN, Sahu P, Verma R. Modulation of mesalamine release from enteric-coated matrix tablets using natural polysaccharides for localized colonic delivery. JAPR. 2024;12(2):93\u2013108. https:\/\/doi.org\/10.18231\/j.joapr.2024.12.2.93.108.","journal-title":"JAPR"},{"key":"3459_CR43","doi-asserted-by":"publisher","unstructured":"Sameina LH, Idamakantia S, Chettupalli AK, Velamala RR, Ezzat MO. Design of mesalamine loaded micro-particles: preparation, in vitro and in-vivo characterization. Materials Today: Proceedings. 2023;S2214785323039251. https:\/\/doi.org\/10.1016\/j.matpr.2023.07.063.","DOI":"10.1016\/j.matpr.2023.07.063"},{"key":"3459_CR44","doi-asserted-by":"publisher","unstructured":"Seifirad S. Design and Characterization of Mesalamine Loaded Nanoparticles for Controlled Delivery System. Nanomed Res J. 2016;97\u2013106. https:\/\/doi.org\/10.7508\/nmrj.2016.02.006.","DOI":"10.7508\/nmrj.2016.02.006"},{"issue":"2","key":"3459_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1006\/jcis.2001.7837","volume":"243","author":"Y Xue","year":"2001","unstructured":"Xue Y, Zhao Q, Luan C. The thermodynamic relations between the melting point and the size of crystals. J Colloid Interface Sci. 2001;243(2):388\u201390. https:\/\/doi.org\/10.1006\/jcis.2001.7837.","journal-title":"J Colloid Interface Sci"},{"key":"3459_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/30415","volume":"393","author":"M Schmidt","year":"1998","unstructured":"Schmidt M, Kusche R, Von Issendorff B, Haberland H. Irregular variations in the melting point of size-selected atomic clusters. Nature. 1998;393:238\u201340. https:\/\/doi.org\/10.1038\/30415.","journal-title":"Nature"},{"key":"3459_CR47","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.3390\/ma17235689","volume":"17","author":"M Gao","year":"2024","unstructured":"Gao M, Zhao S, Yang H, Wu X, Xiao Y. An analysis of the influence of DSC parameters on the measurement of the thermal properties of phase-change material. Materials. 2024;17:5689. https:\/\/doi.org\/10.3390\/ma17235689.","journal-title":"Materials"},{"key":"3459_CR48","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1021\/acs.molpharmaceut.4c00601","volume":"21","author":"NA Bhale","year":"2024","unstructured":"Bhale NA, Shah S, Jahnavi AS, Vishwakarma A, Thakur TS, Thomas SP, et al. Three strikingly different crystal habits of Tadalafil: design, characterization, pharmaceutical performance, and computational studies. Mol Pharmaceutics. 2024;21:6234\u201344. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00601.","journal-title":"Mol Pharmaceutics"},{"key":"3459_CR49","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.3390\/app11125604","volume":"11","author":"SR Datir","year":"2021","unstructured":"Datir SR, Kumar D, Kumar P, Jain S, Bansal AK, Nallamothu B, et al. Study of different crystal habits of Aprepitant: dissolution and material attributes. Appl Sci. 2021;11:5604. https:\/\/doi.org\/10.3390\/app11125604.","journal-title":"Appl Sci"},{"key":"3459_CR50","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3109\/03639040903025830","volume":"35","author":"KC Pingali","year":"2009","unstructured":"Pingali KC, Saranteas K, Foroughi R, Muzzio FJ. Practical methods for improving flow properties of active pharmaceutical ingredients. Drug Dev Ind Pharm. 2009;35:1460\u20139. https:\/\/doi.org\/10.3109\/03639040903025830.","journal-title":"Drug Dev Ind Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03459-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:04:16Z","timestamp":1790276656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3459"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03459-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Yes). The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: (No).","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"220"}}